Benzinga’s Top Ratings Upgrades, Downgrades For May 2, 2023
Upgrades According to Colliers Securities, the prior rating for Centerspace (NYSE:CSR) was changed from Neutral to Buy. In…
IMV Initiates Restructuring Proceedings Under The CCAA To Complete The Review Of Its Strategic Alternatives
IMV Inc. (the "Company" or "IMV") (NASDAQ:IMV, TSX:IMV), a clinical-stage biopharmaceutical Company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and
IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
IMV Inc. ("IMV" or the "Company") (NASDAQ:IMV, TSX:IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and
HC Wainwright & Co. Reiterates Buy on IMV – 1-for-10 reverse stock
HC Wainwright & Co. analyst Joseph Pantginis reiterates IMV (NASDAQ:IMV) with a Buy, 1-for-10 reverse stock
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.
IMV Stock Falls After Interim Data From Lead Candidate In Blood Cancer Subtype
IMV Inc (NASDAQ:IMV) announced preliminary data from the VITALIZE Phase 2B trial evaluating its lead DPX product, maveropepimut-S (MVP-S), in combination…